Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Eosinophilic Asthma”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Not applicableUnknownNCT04512521
What this trial is testing

Functional Lung MRI for Early Treatment Response Assessment for Patients With Eosinophilic Asthma

Who this might be right for
Asthma; Eosinophilic
Hannover Medical School 40
Post-approval studies (Phase 4)Active Not RecruitingNCT03953300
What this trial is testing

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics

Who this might be right for
Asthma
AstraZeneca 75
Not applicableUnknownNCT05139381
What this trial is testing

Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab

Who this might be right for
Asthma in Children
King's College Hospital NHS Trust 148
Not applicableStudy completedNCT05603845
What this trial is testing

Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients

Who this might be right for
Severe Asthma
AstraZeneca 291
Large-scale testing (Phase 3)Ended earlyNCT04049175
What this trial is testing

Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma

Who this might be right for
Asthma; Eosinophilic
Chiesi Farmaceutici S.p.A. 810
Testing effectiveness (Phase 2)Active Not RecruitingNCT06680947
What this trial is testing

A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma

Who this might be right for
Asthma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 225
Not applicableStudy completedNCT05091385
What this trial is testing

Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma

Who this might be right for
Asthma; Eosinophilic
Medical University of Lodz 106
Large-scale testing (Phase 3)Study completedNCT05243680
What this trial is testing

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

Who this might be right for
Asthma
GlaxoSmithKline 641
Post-approval studies (Phase 4)Study completedNCT04710134
What this trial is testing

Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma

Who this might be right for
Asthma; Eosinophilic
McMaster University 10
Testing effectiveness (Phase 2)Study completedNCT03469934
What this trial is testing

Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
AnaptysBio, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT02377427
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children

Who this might be right for
Asthma
GlaxoSmithKline 36
Large-scale testing (Phase 3)Ended earlyNCT03052725
What this trial is testing

Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma

Who this might be right for
Eosinophils, Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 391
Post-approval studies (Phase 4)Study completedNCT04276233
What this trial is testing

Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma

Who this might be right for
Asthma
GlaxoSmithKline 100
Post-approval studies (Phase 4)Study completedNCT04159519
What this trial is testing

Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

Who this might be right for
AsthmaSevere Eosinophilic Asthma
AstraZeneca 170
Not applicableStudy completedNCT05147155
What this trial is testing

Impulse Oscillometry Measurements in Severe Eosinophilic Asthmatics Before and After Anti-IL-5 Factor Initiation

Who this might be right for
Severe Asthma
University of Thessaly 130
Large-scale testing (Phase 3)Study completedNCT03099096
What this trial is testing

Study of Mepolizumab Autoinjector in Asthmatics

Who this might be right for
Asthma
GlaxoSmithKline 159
Not applicableActive Not RecruitingNCT06069310
What this trial is testing

Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma

Who this might be right for
Chronic Rhinosinusitis With Nasal PolypsSevere Eosinophilic AsthmaChronic Rhinosinusitis Without Nasal Polyps
National and Kapodistrian University of Athens 40
Post-approval studies (Phase 4)Study completedNCT02654145
What this trial is testing

Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients

Who this might be right for
Asthma
GlaxoSmithKline 145
Not applicableUnknownNCT05365841
What this trial is testing

Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP).

Who this might be right for
Severe Eosinophilic Asthma w/wo CRSwNP
University of Crete 85
Large-scale testing (Phase 3)Active Not RecruitingNCT06465485
What this trial is testing

STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

Who this might be right for
Severe Eosinophilic Asthma
AstraZeneca 504
Load More Results